Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Qrons Inc
(OP:
QRON
)
0.1855
UNCHANGED
Last Price
Updated: 12:55 PM EST, Mar 8, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
0.1855
Bid (Size)
N/A (0)
Ask (Size)
N/A (0)
Prev. Close
0.1855
Today's Range
0.1855 - 0.1855
52wk Range
0.1557 - 0.7450
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Qrons Announces the Addition of Professor Shiri Navon-Venezia to its Scientific Advisory Board to Beef up its Team, as Part of its New Sepsis Research Program
November 20, 2023
Via
ACCESSWIRE
Qrons Announces Launch of its New Website in Furtherance of its Neuronal and Infectious Disease Treatments Development, Including Sepsis
August 23, 2023
Via
ACCESSWIRE
Performance
YTD
-2.93%
-2.93%
1 Month
N/A
N/A
3 Month
-19.35%
-19.35%
6 Month
-41.28%
-41.28%
1 Year
-53.63%
-53.63%
More News
Read More
Qrons Announces the Filing of a Provisional Patent Application in Furtherance of its Neuronal and Infectious Disease Treatments Development, Including Sepsis
August 14, 2023
Via
ACCESSWIRE
Qrons Announces the Signing of a License Agreement Term Sheet as Part of New Research Program to Experiment and Commercialize the Therapeutic Effect of Certain Tellurium Based Compounds on Antibiotic Resistance Bacterial Infections, Sepsis and Traumatic
July 20, 2023
Via
ACCESSWIRE
Qrons files U.S. National Phase of its Patent Application in Furtherance of its QS200 Product Candidate for Therapeutic Polypseudorotaxane Hydrogels
March 22, 2023
Via
ACCESSWIRE
Qrons Announces Engagement of Israeli Intellectual Property Law Firm IPK to Develop Roadmap for Its New Product Line
January 17, 2023
Via
ACCESSWIRE
Qrons Announces a New Pre-Clinical Research Program to Test the Efficacy of Tellurium Based Compounds, in Combination with its QS200(TM) Product Candidate or Independently, in Treating Diffused Axonal Injuries and Antibiotic Resistant Bacteria and Sepsis
December 14, 2022
Via
ACCESSWIRE
Qrons Announces Filing Of Provisional Patent Application In Furtherance Of Its QS200 Product Candidate
April 12, 2022
From
Qrons Inc.
Via
AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
Qrons Announces Effectiveness of Its Post-Effective Amendment to Its Registration Statement
March 28, 2022
From
Qrons Inc.
Via
AccessWire
Topics
Intellectual Property
Regulatory Compliance
Exposures
Intellectual Property
Legal
Regulatory
Qrons Announces U.S. Patent Office Grants Dartmouth College 3D Printing Patent Forming Basis of License Agreement with Qrons
April 22, 2021
From
Qrons Inc.
Via
AccessWire
Topics
Artificial Intelligence
Intellectual Property
Exposures
Artificial Intelligence
Intellectual Property
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.